New metabolites of the drug 5-aminosalicylic acid. I: N-β-D-glucopyranosyl-5-aminosalicylic acid

References

• Khan Azad A. K., Piris J., Truelove S. C. An experiment to determine the active therapeutic moity of sulphasalazine. Lancet 1977; ii: 892–895
   Google Scholar
• Bondesen S., Rasmussen S. N., Rask-Madsen J., Nielsen O. H., Lauritsen K., Binder V., Hansen S. H., Hvidberg E. F. 5-Aminosalicylic acid in the treatment of inflammatory bowel disease. Acta Medica Scandinavica 1987; 221: 227–242
   PubMedGoogle Scholar
• Breitmaier E., Voelter W. ¹³C NMR Spectroscopy, 2nd. edn. Monographs in Modern Chemistry, 5, Verlag Chemie, Winheim 1978; 248
   Google Scholar
• Brendel E., Meineke I., Witsch D., Zschunke M. Simultaneous determination of 5-aminosalicylic acid and acetylaminosalicylic acid by high-performance liquid chromatography. Journal of Chromatography 1987; 385: 299–304
   PubMedGoogle Scholar
• Campieri M., Lanfranchi G. A., Bazzocchi G., Bringola C., Sarti F., Franzin G., Battocchia A., Labo G., Dal Monte P. R. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet 1981; ii: 270–271
   Google Scholar
• Capron B. Mechanisms in carbohydrate chemistry. Chemical Reviews 1969; 69: 407–496
   Google Scholar
• Duggan D. E., Baldwin J. J., Arison B. H., Rhodes R. E. N-glucoside formation as a detoxification mechanism in mammals. Journal of Pharmacology and Experimental Therapeutics 1974; 190: 563–569
   PubMed Web of Science ®Google Scholar
• Fischer C., Maier K., Klotz M. Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine. Journal of Chromatography, Biomedical Applications 1981; 225: 498–503
   PubMedGoogle Scholar
• Fischer C., Maier K., Stumpf E., von Gaisberg M., Klotz M. Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine in man. European Journal of Clinical Pharmacology 1983a; 25: 511–515
   PubMed Web of Science ®Google Scholar
• Fischer C., Maier K., Klotz M. Specific measurement of 5-aminosalicylic acid and its acetylated metabolite in human bile. British Journal of Clinical Pharmacology 1983b; 15: 273–274
   PubMed Web of Science ®Google Scholar
• Funcke W., Klemer A. Notiz über die Identifizirung und Sturaufklärung einiger Amadoriverbindugen durch 13C-NMR-Spectroskopie. Liebigs Annalen der Chemie 1975; 1232–1235
   Google Scholar
• Hansson K-A. Determination of free and acetylated 5-aminosalicylic acid in serum and urine after administration of salicylazosulphapyridine. Acta Pharmaceutica Sueciea 1973; 10: 153–155
   PubMedGoogle Scholar
• van Hees P. A. M., Bakker J. H., van Tongeren J. H. M. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. Gut 1980; 21: 632–635
   PubMed Web of Science ®Google Scholar
• van Hogezand R. A., van Balen H. C. J. G., van Schaik A., Tangerman A., van Hees P. A. M., Zwanenburg B., van Tongeren J. H. M. Determination of sodium azodisalicylate, salazosulphapyridine and their metabolites in serum, urine and faeces by high-performance liquid chromatography. Journal of Chromatography, Biomedical Applications 1984; 305: 470–476
   PubMed Web of Science ®Google Scholar
• Ishidate M., Takitani S., Kishi T. Arylamine N-glucuronide and its structure. Chemical and Pharmaceutical Bulletin 1959; 7: 291–294
   Google Scholar
• Kalow W., Tang B. K., Kadar D., Inaba T. Distinctive patterns of amobarbital metabolites. Clinical Pharmacology and Therapeutics 1978; 24: 576–582
   PubMedGoogle Scholar
• Kaspersen F. M., van Boeckel C. A. A. A review of the methods of chemical synthesis of sulphate and glucuronide conjugates. Xenobiotica 1987; 17: 1451–1471
   PubMed Web of Science ®Google Scholar
• Lee F. J. D., Ang S. B. Simple and sensitive high-performance liquid chromatographic assay for 5-aminosalicylic acid and acetyl-5-aminosalicylic acid in serum. Journal of Chromatography, Biomedical Applications 1987; 413: 300–304
   PubMed Web of Science ®Google Scholar
• Manis M. O., Braselton W. E. Metabolism of 4,4′-methylenebis(2-chloroaniline) by canine liver and kidney slices. Drug Metabolism and Disposition 1986; 14: 166–174
   PubMedGoogle Scholar
• Paulson G. D., Griddings J. M., Lamoreaux C. H., Mansager E. R., Struble C. B. The isolation and identification of 14C-sulfamethazine (4-amino-N-(4,6-dimethyl-2-pyrimidyl) ‘14C’ benzensulfonamide) metabolites in the tissues and excreta of swine. Drug Metabolism and Disposition 1981; 9: 142–146
   PubMed Web of Science ®Google Scholar
• Riley S. A., Mani V., Goodman M. J., Herd M. E., Dutt S., Turnberg L. A. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 1988; 94: 1383–1389
   PubMed Web of Science ®Google Scholar
• Schroeder K. W., Tremaine W. J., Ilstrup D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. New England Journal of Medicine 1987; 317: 1625–1629
   PubMed Web of Science ®Google Scholar
• Soine W. H., Soine P. J., Overton B. W., Garrettson L. K. Product enatioselectivity in the N-glucosylation of amobarbital. Drug Metabolism and Disposition 1986; 14: 619–621
   PubMed Web of Science ®Google Scholar
• Takitani S. Alkylamine N-glucuronides and their stability in the solution. Chemical and Pharmaceutical Bulletin 1959; 7: 845–848
   Google Scholar
• Tang B. K., Kalow W. Amobarbital metabolism in man: N-glucoside formation. Research Communications in Chemical Pathology and Pharmacology 1978; 21: 45–53
   PubMedGoogle Scholar
• Tang B. K., Kalow W., Grey A. A. Metabolic fate of phenobarbital in man: N-glucoside formation. Drug Metabolism and Disposition 1979; 7: 315–318
   PubMed Web of Science ®Google Scholar